Alcohol Dependence Clinical Trial
Official title:
Component Analysis of Motivational Interviewing
The purpose of this pilot study is to investigate the critical components of motivational interviewing (MI), a psychotherapeutic intervention, in reducing heavy or problematic drinking. The study will disaggregate MI into its component parts and test full MI compared to MI without its directive strategies. This study will test whether the directive elements of MI are critical or whether MI effects may be attributable solely to its Rogerian, non-directive components. For more information, go to www.projectmotion.org
Motivational interviewing (MI) has been demonstrated to be an effective intervention for
alcohol use disorders (AUD). The consistency, magnitude, and durability of its effects
suggest powerful mechanisms of behavior change (MOBC) operate to reduce drinking. A better
understanding of the MOBC in MI is therefore important. Existing MOBC studies of MI have
yielded limited and contradictory findings. The project proposes to conduct a small pilot
study to disaggregate MI into its component parts and test full MI compared to MI without
its directive strategies. This test will compare whether the directive elements of MI (Full
MI, or FMI) are critical or whether MI effects may be attributable solely to its Rogerian,
non-directive components (aka, Spirit-Only MI, or SOMI).
In addition, we will test whether hypothesized main effects of FMI are mediated via
increases in commitment to reduce drinking early in treatment. Further, we will examine
whether non-specific therapy factors alone (SOMI) significantly reduce drinking when
compared to a Feedback Followed by Counseling (FFC) condition that controls for non-therapy
factors and incorporates assessment and self-monitoring. We will also test whether SOMI's
main effects are mediated by increases in mood and greater belief in the ability to change,
as hypothesized by various theories.
Our work on MOBC for MI will take place in the context of studying brief, stand-alone
treatments for individuals with primary AUD who seek to reduce, but not stop, drinking. We
will recruit 90 individuals with AUD seeking treatment; collect daily process data during a
pre-treatment week; and then assess and randomly assign them to 3 conditions: FMI, SOMI, and
FFC. All participants will be followed for 9 weeks using daily Interactive Voice Recording
(IVR) and in-laboratory assessments at weeks 0, 1, 4, and 8. Those in treatment conditions
will receive 4 sessions of treatment at weeks 1, 2, 4, and 8. FFC will receive treatment
after completing the week 8 assessment period. Participants in FMI and SOMI will be followed
for an additional 4 weeks post-treatment (week 12).
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02901041 -
Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism
|
Phase 3 | |
Completed |
NCT03340051 -
Remote Alcohol Monitoring and Episodic Thinking
|
N/A | |
Not yet recruiting |
NCT06444243 -
Psilocybin-assisted Therapy for Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02486900 -
Neurofeedback & Alcohol Dependence
|
N/A | |
Completed |
NCT02705898 -
Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women
|
N/A | |
Completed |
NCT02179749 -
Mifepristone Treatment of Alcohol Use Disorder
|
Phase 2 | |
Completed |
NCT02197598 -
Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use
|
Phase 4 | |
Recruiting |
NCT02385643 -
The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients
|
N/A | |
Completed |
NCT01828866 -
Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients
|
N/A | |
Terminated |
NCT01408641 -
Topiramate for Alcohol Use in Posttraumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT01182766 -
New Treatment for Alcohol and Nicotine Dependence
|
Phase 2/Phase 3 | |
Completed |
NCT02193204 -
Chronic Alcohol, Stress Inflammatory Response and Relapse Risk
|
N/A | |
Completed |
NCT01342549 -
Treatment Strategy for Alcohol Use Disorders in Veterans With TBI
|
Phase 3 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT01165541 -
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
|
Phase 2 | |
Completed |
NCT00585780 -
Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse
|
Phase 1/Phase 2 | |
Completed |
NCT01056484 -
Mindfulness Meditation for Health
|
Phase 2 | |
Completed |
NCT00607620 -
Disseminating Organizational SBI Services at Trauma Centers
|
N/A | |
Completed |
NCT00884884 -
Aripiprazole and Topiramate on Free-Choice Alcohol Use
|
Phase 2/Phase 3 | |
Completed |
NCT00463346 -
Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism
|
Phase 3 |